Search
for
Sort by
Research 331–360 of 1000+
- Identification and Characterization of Two Se6OMTs from Stephania epigaea Offer Novel Insights into the Biosynthetic Pathway of Cepharanthine
- The green healer: an updated review on the phytochemical profile and therapeutic potential of Aloe vera
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
- Testosterone: The Male Sex Hormone
- Choice of treatment for women with polycystic ovary syndrome
- Polycystic ovary syndrome: a dermatologic approach
- Histopathological change of age-related hearing loss in female advance-aged CBA/CaJ mice
- Anthracycline analogs The past, present, and future
- Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Idiopathic Hirsutism*
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Simultaneous determination of minoxidil and minoxidil sulfate by high-performance liquid chromatography with UV-detection and its applications
- Hormonal control of 5.ALPHA.-reductase activity in hamster sebaceous glands.
- The involvement of androgens in human hair growth
- Cutaneous drug reactions
- Ferulic acid promotes hair growth via estrogen receptor alpha activation in cultured human dermal papilla cells
- Management OF Patients with Polycystic Ovary Syndrom
- Understanding Polycystic Ovary Syndrome
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- SÍNDROME DOS OVÁRIOS POLICÍSTICOS E MANIFESTAÇÕES DERMATOLÓGICAS: DO DIAGNÓSTICO À TERAPÊUTICA ESTÉTICA
- Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Dermatological drugs, topical agents, and cosmetics
- Inhibition of 5α-Reductase Activity in SZ95 Sebocytes and HaCaT Keratinocytes <i>In Vitro</i>
- The integrated stress response fine-tunes stem cell fate decisions upon serine deprivation and tissue injury
- Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome